These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 27987544
1. Clinical Trials in FSGS: Past Challenges and New Trial Designs. Gipson D. Semin Nephrol; 2016 Nov; 36(6):453-459. PubMed ID: 27987544 [No Abstract] [Full Text] [Related]
2. The treatment of idiopathic focal segmental glomerulosclerosis in adults. Hogan J, Radhakrishnan J. Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833 [Abstract] [Full Text] [Related]
3. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report. Kolonko A, Piecha G, Więcek A. Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154 [Abstract] [Full Text] [Related]
4. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis. Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS. Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086 [Abstract] [Full Text] [Related]
9. Focal segmental glomerulosclerosis in children. Jellouli M, Abidi K, Askri M, Ferjani M, Naija O, Hammi Y, Goucha R, Gargah T. Tunis Med; 2016 May; 94(5):356-359. PubMed ID: 27801486 [Abstract] [Full Text] [Related]
11. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study. Soliman AR, Maamoun H, Soliman H, Ahmed RM. Rom J Intern Med; 2021 Jun 01; 59(2):127-133. PubMed ID: 33565308 [Abstract] [Full Text] [Related]
12. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. McCarthy ET, Sharma M, Savin VJ. Clin J Am Soc Nephrol; 2010 Nov 01; 5(11):2115-21. PubMed ID: 20966123 [Abstract] [Full Text] [Related]
13. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis. Shatat IF, Schoeneman M, Flynn JT, Woroniecki RP. Pediatr Nephrol; 2007 Jun 01; 22(6):834-9. PubMed ID: 17294224 [Abstract] [Full Text] [Related]
14. Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middleton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL. Kidney Int; 2011 Mar 01; 79(6):678-685. PubMed ID: 21178977 [Abstract] [Full Text] [Related]
15. Pregnancy, Proteinuria, Plant-Based Supplemented Diets and Focal Segmental Glomerulosclerosis: A Report on Three Cases and Critical Appraisal of the Literature. Attini R, Leone F, Montersino B, Fassio F, Minelli F, Colla L, Rossetti M, Rollino C, Alemanno MG, Barreca A, Todros T, Piccoli GB. Nutrients; 2017 Jul 19; 9(7):. PubMed ID: 28753930 [Abstract] [Full Text] [Related]
16. Treatment of FSGS in Children. Sethna CB, Gipson DS. Adv Chronic Kidney Dis; 2014 Mar 19; 21(2):194-9. PubMed ID: 24602468 [Abstract] [Full Text] [Related]
17. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis. Chiou YY, Lee YC, Chen MJ. Curr Med Res Opin; 2017 Aug 19; 33(8):1389-1399. PubMed ID: 28436233 [Abstract] [Full Text] [Related]
18. Glomerular podocyte vacuolation in focal segmental glomerulosclerosis. Yoshikawa N, Ito H, Akamatsu R, Hazikano H, Okada S, Matsuo T. Arch Pathol Lab Med; 1986 May 19; 110(5):394-8. PubMed ID: 3754422 [Abstract] [Full Text] [Related]
19. Other immunosuppressive agents for focal segmental glomerulosclerosis. Ponticelli C, Passerini P. Semin Nephrol; 2003 Mar 19; 23(2):242-8. PubMed ID: 12704585 [Abstract] [Full Text] [Related]
20. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis. Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D. Expert Opin Investig Drugs; 2018 Nov 19; 27(11):839-879. PubMed ID: 30360670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]